Israel is known as a leader in “high tech” agriculture. Now, the country is attracting US companies who are seeking to bring medical cannabis research and development to the states. Yahoo News reports: Since 2014, U.S. firms have invested about $50 million in licensing Israeli medical marijuana patents, cannabis agro-tech startups and firms developing delivery devices such as inhalers, said Saul Kaye, CEO of iCAN, a private cannabis research hub. “I expect it to grow to $100 million in the coming year,” Kaye said at iCAN’s CannaTech conference in Tel Aviv this month, one of the largest gatherings of medical marijuana experts. Scientists say strict rules, some set by the Drug Enforcement Administration, limit cannabis studies in the United States, where the legal marijuana market is valued at $5.7 billion and expected to grow to $23 billion by 2020. “In the United States it’s easier to study heroin than marijuana,” said U.S. psychiatrist Suzanne Sisley, who has researched the effects of cannabis as a treatment for American military veterans suffering from Post Traumatic Stress Disorder. “With marijuana you have to go through added layers of government red tape. It highlights the way marijuana research is being shackled by politics,” said [...]